Stocks
Agios Pharmaceuticals (AGIO) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -2 672% | -1 435% | -1 151% | -756.3% | -712.0% | |||
| Changes by years, y/y, % | +1 237pp | +284pp | +395pp | -34.3% | |||||
Agios Pharmaceuticals. EBITDA margin, %
Agios Pharmaceuticals. EBITDA margin, changes, pp
Agios Pharmaceuticals (AGIO) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | -1 207% | -889.3% | -792.4% | -539.8% | -471.2% | -712.0% | |
| Changes by years, y/y, % | -99pp | +321pp | +340pp | +613pp | +736pp | |||
| Changes by quarters, q/q, % | -55pp | +318pp | +97pp | +253pp | +69pp | |||
